12
Total investments
2
Early stage
3
Mid stage
3
Late stage
10y
Years active
Portfolio
9 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Angel Investor
2024
The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC.
Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME).
Seekyo’s lead compound SKY01 induces a selective tumor self-destruction:
• Efficacy and safety validated in small and large animals (e.g. Dogs).
• Unprecedented antitumor efficacy vs. Standards of Care
• Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal…)
• Low Cost of Goods
Angel Investor
2024
Praxy.ai, founded by doctors and AI engineers, has developed an AI suite for healthcare professionals, our products free up their time, while improving the completeness and precision of therapeutic patient monitoring.
Our first product on the market is a multi-channel solution (physical consultation, telephone, videoconferencing, mobility) which automatically generates consultation reports and updates patients medical records.
Angel Investor
2024
MyEasyFarm is a French AgTech startup, founded in 2017, dedicated to transforming agriculture through digital innovation. We empower farmers and agri-food companies in their transition to regenerative and low-carbon agriculture.
Our platform offers cutting-edge solutions for data collection, analysis, and reporting, helping optimize farming practices and reduce environmental impact.
With offices in multiple countries and a team of 25 experts, MyEasyFarm leads the way in precision farming, carbon farming, and sustainable agriculture through the following solutions:
- MyEasySpheres: An adaptable MRV platform, developed with BIOSPHERES, supporting agribusinesses in regenerative agriculture projects.
- MyEasyCarbon: A carbon farming solution certified by Bureau Veritas and compliant with international standards like Verra and Gold Standard, facilitating carbon credit generation.
- MyEasyFarm: A precision farming platform that collects, organizes, and analyzes agricultural data to enhance farming practices and reduce inputs, ISOBUS-certified for seamless connectivity.
Angel Investor
2024
French start-up Artifeels mission is to enable infrastructure operators to ensure the continuity and availability of their services (telecoms, energy, water, gas, rail networks, real estate, etc.), by protecting even the most complex technical infrastructures from third-party attacks.
How can we do this?
By reinventing physical infrastructure protection and monitoring technologies thanks to AI Edge and IoT.
Tech start-up, Artifeel designs and markets intelligent, connected and autonomous alarm systems that adapt to every structure, even the most isolated and complex.
A specialist in embedded Artificial Intelligence and IoT, Artifeel has patented “Check-In” technology, the industrys only 100% autonomous system, requiring neither Wi-Fi nor electricity, for 24/7 protection from the moment it is installed.
Technologies designed, manufactured and continuously perfected in France by our teams based in Paris and Lyon.
Since our creation in 2021, the innovative nature of our technology and approach has been recognized by 10 innovation prizes and awards: Trophées de la sécurité 2022 et 2024, innovation award at CES2023, selected French Tech, Startup Gold Trophy at ExpoProtection and APS,...
To find out more, visit www.artifeel.com or
or contact us at contact@artifeel.com
Angel Investor
2023
Pied-à-terre près du bureau pour navetteurs
Vivre éloigné de son lieu de travail est une réalité pour de nombreux actifs que ce soit temporaire (période d’essai, attente déménagement famille lors d’une prise de poste, mission éloignée, formation) ou dans la durée (bi-localisés, meilleur cadre de vie).
Un même besoin : se loger en semaine près du lieu de travail.
WeekAway met les navetteurs en relation avec des particuliers qui ont une chambre ou un logement disponible en semaine.
- pour le locataire : le confort d’un même lieu chaque semaine, dans lequel il peut laisser ses affaires, au juste prix selon le temps d’occupation.
- Pour l’hébergeur : un complément de revenus, un locataire de confiance peu présent, une location flexible qui permet d’utiliser le bien en son absence
Une offre originale qui séduit les entreprises : élargit le bassin de recrutement, favorise les mobilités et renforce l’attractivité auprès des Talents. Et permet une réelle économie sur les frais d’hébergement.
Contactez-nous pour en savoir plus sur nos solutions et partager nos cas utilisateurs.
Angel Investor
2023
L’équipe HUBLEX conçoit, développe et commercialise des solutions de déplacement
innovantes à destination des professionnels parcourant de longues distances sur
leurs lieux de travail. Cette activité repose sur le savoir-faire développé par HUBLEX sur la simplification de la
conception industrielle de gyropode et l’écoute des attentes du marché en matière de mobilité.
HUBLEX propose un outil professionnel de déplacement unipersonnel de nouvelle génération de type gyropode
permettant de décupler la mobilité des professionnels sur leurs lieux de travail, de réduire la pénibilité au travail,
de diminuer le bilan carbone des entreprises et de donner une image moderne à ces sociétés.
Le gyropode HUBLEX présente les caractéristiques suivantes :
• léger ,
• encombrement réduit ,
• déplacement en zones étroites/encombrées,
• maintenance réduite,
• autonomie sans limite,
• écologique/électrique (0 particule émise),
• économique.
Angel Investor
2023
Cognitive Engines est un intégrateur robotique collaborative. Notre Intelligence Artificielle propriétaire est couplée à de la vision temps réel, qui lui permet de reconnaitre et piloter des bras robots industriels pour prendre des objets en mouvement.
Nos cobots sadaptent au changement de taille produits, sans reprogrammation.
Notre interface IHM est le geste de la main pour éviter de souiller ou de rayer les écrans tactiles, ou de changer en permanence ses gants.
Linterface Homme-Machine est le geste de la main. Grâce à une sémantique du geste, lopérateur na aucune connaissance en informatique à connaître.
Notre IA est compatible avec de nombreuses marques de robotiques.
Angel Investor
2023
Safehear is a company that develops technologies and manufactures products in the field of employee protection.
Partnership Board Member
2016
The European Cyber Security Organisation (ECSO) ASBL – www.ecs-org.eu – is a fully independent non-profit organisation under the Belgian law, established in June 2016.
Since 2016, ECSO has been the privileged partner of the European Commission for the implementation of the European Cyber Security Public-Private Partnership (cPPP).
ECSO works with its Members and Partners to develop a competitive European cybersecurity ecosystem providing trusted cybersecurity solutions protection the growth of the European Digital Single Market and advancing Europe’s cybersecurity posture while reducing its technological dependence.
As of the end of 2022, ECSO is leading the strategic support action for the development of the European Cybersecurity Community (ECCO) in the frame of the ECCC regulation, gathering all European actors.
ECSO Members include a wide variety of stakeholders such as large companies, SMEs and start-ups, research centers, universities, clusters and associations, users and operators, as well as local, regional and national administrations. ECSO Members originate from EU Member States, countries part of the European Economic Area (EEA), the European Free Trade Association (EFTA) and associated countries.
Experience · 17 entries
All (17)
Investments (12)
Founder (2)
Board (1)
2026
Investment Associate | Strategic Committee Member
2026
EYESEE Solution makes inventory activities in warehouses faster, safer and better than ever !
In warehouses, inventories require significant human and material resources. They involve renting cherry pickers and stopping operations to allow operators to scan all the components which make up the stock, one by one: pallets, boxes, items…
The Eyesee drone inventory solution is designed to simplify and secure the control of stocks and locations of merchandise stored in pallet-racks in warehouses. At the entrance to each aisle, the operator drops off the drone. Then, using its sensors and indoor geolocation system, Eyesee moves through each aisle of the warehouse according to a predetermined flight plan. Its cameras capture information from the relevant logistics labels for stock-taking. The operator views the captured data on the tablet in real time and can interact with the drone if it cannot find the bar code. The captured data are then sent to the warehouse management system (WMS) or the ERP solution, so that any stock or location errors can be identified.
Investment Associate | Strategic Committee Member
2026
Plantibodies is a biotech developing a sustainable platform to produce and deliver oral biologics with increased efficacy and less adverse side effects for the patients. Thanks to molecular farming and synthetic biology, our technology enables to produce humanized monoclonal antibodies within edible plant leaves instead of using animal cells, while drastically reducing carbon footprint, slashing production costs by over 90%, and offering medications with remarkable room temperature stability. By effortless storage and a potential worldwide distribution to treat diseases at home such as cancers, inflammations, metabolic diseases and infections, Plantibodies avoids burdensome intravenous injections at hospital while positively impacting lives globally.
2024
Investment Associate | Strategic Committee Member
2024
We develop colorful organic solar cells, allowing brands to integrate a sustainable power source into their products without compromising their design.
We reduce the need for batteries and chargers for everyday objects by making them energy self-sufficient.
Angel Investor
2024
The heterogeneity of cancer cells constitutes a strong limitation for the treatment of solid cancers like pancreas and Breast TNBC.
Shifting to a new paradigm, Seekyo, a pre-clinical biotech Co. overpowers this challenge by targeting specific functional proteins selectively produced within the Tumor Micro-Environment (TME).
Seekyo’s lead compound SKY01 induces a selective tumor self-destruction:
• Efficacy and safety validated in small and large animals (e.g. Dogs).
• Unprecedented antitumor efficacy vs. Standards of Care
• Efficient in several tumors (Pancreas, Triple Negative Breast Cancer, lung, colorectal…)
• Low Cost of Goods
Angel Investor
2024
Praxy.ai, founded by doctors and AI engineers, has developed an AI suite for healthcare professionals, our products free up their time, while improving the completeness and precision of therapeutic patient monitoring.
Our first product on the market is a multi-channel solution (physical consultation, telephone, videoconferencing, mobility) which automatically generates consultation reports and updates patients medical records.
Show all 17 entries ↓
Investment activity
2016–2024 · 12 investments
Recent (last 2 years)Earlier
